News Focus
News Focus
Followers 480
Posts 61846
Boards Moderated 15
Alias Born 09/20/2001

Re: Whatsupp post# 2964

Friday, 04/07/2017 8:44:38 PM

Friday, April 07, 2017 8:44:38 PM

Post# of 21574
The FDA doesn't "approve" P2s, they "approve" P3.

Anavex CEO has stated that they are in touch with the FDA concerning trial design.

Missling has been extremely conservative in diluting the stock and I don't expect that to change.




In Peace, In War

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TAOX News